Gilead Sciences Inc (GILD)

Exchange
NASDAQ
Symbol
GILD
Sector
Life Sciences
Industry
Biological Products, (no Disgnostic Substances)
Description
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Country
USA

Stock price

At close: October 21, 2025

  • Open
    123.27
  • High
    124.61
  • Low
    121.92
  • Close
    124.08
  • Volume
    5,559,030

Financial ratios

Dec 31, 2024